Liraglutide Improves Both Diabetic Nephropathy and Cardiomyopathy in the SDT Fatty Rat, a Cardiorenal Model of Type 2 Diabetes.

Key Word：
Glucagon-Like Peptide 1 (GLP-1) 、Liraglutide、Diabetic Nephropathy、Cardiomyopathy、Heart failure with preserved ejection function (HFpEF)、Cardiorenal、obese, type 2 diabetic model

BRIAND PhD, F*¹, Shinohara, M², Kageyama, Y², Sulpice, T¹

¹PHYSIOGENEX, RESEARCH, ESCALQUENS, France, ²CLEA Japan Inc., Business Development, Tokyo, Japan

For more details, please click here (Google Search)

• ERA 2022: Paris Expo Porte de Versailles, Paris, Ile-de-France, France.
• May 19-22, 2022 

Related CLEA Japan product: SDT fatty/Jcl

For the animal model, please click here ▼

 https://www.clea-japan.com/en/products/diabetes/item_a0150

 

Inquiry

If you have any questions, please feel free to contact us.